SPL 1.11% 9.1¢ starpharma holdings limited

Replacement or Expansion, page-34

  1. 3,498 Posts.
    lightbulb Created with Sketch. 835
    Starpharma still haven’t changed the error in their advertisement on Seek. Perhaps they should be recruiting for a proof reader instead.

    I’ve posted the following before but it’s just the most unbelievable howler of an ASX announcement:

    ”Starpharma today announced positive interim results from its ongoing phase 2 trial of DEP cabazitaxel, showing that 100% of evaluable patients with hormone refractory metastatic prostate cancer.”

    Showed what?
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.